Sacubitril/Valsartan for heart failure: A protocol for systematic review and meta-analysis

BACKGROUND: Sacubitril–valsartan has been shown to have superior effects over angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with heart failure (HF). However, the effects of sacubitril–valsartan have never been systematically evaluated. Therefore, we performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Wenqin, Luo, Jinlan, Huang, Xianli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276214/
https://www.ncbi.nlm.nih.gov/pubmed/35687770
http://dx.doi.org/10.1097/MD.0000000000029149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276214/
https://www.ncbi.nlm.nih.gov/pubmed/35687770
http://dx.doi.org/10.1097/MD.0000000000029149

Ejemplares similares